M. Baekelandt, M. Castiglione, . Esmo-guidelines-working, and . Group, Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol. mai, vol.20, issue.4, pp.29-31, 2009.
DOI : 10.1093/annonc/mdp120

URL : https://academic.oup.com/annonc/article-pdf/20/suppl_4/iv29/344756/mdp120.pdf

G. Canlorbe, S. Zilberman, M. Ballester, and E. Daraï, Decision and therapeutic tree for endometrial cancer], Rev Prat. juin, vol.64, issue.6, pp.807-819, 2014.

W. Creasman, Revised FIGO staging for carcinoma of the endometrium, International Journal of Gynecology & Obstetrics, vol.105, issue.2, p.109, 2009.
DOI : 10.1016/j.ijgo.2009.02.010

S. Pecorelli, Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium, 103?4. 7. Cancers gynécologiques -Recommandations et outils d'aide à la pratique | Institut National Du Cancer [Internet], 2009.
DOI : 10.1016/j.ijgo.2009.02.012

T. Bosse, E. Peters, C. Creutzberg, I. Jürgenliemk-schulz, J. Jobsen et al., Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer ??? A pooled analysis of PORTEC 1 and 2 trials, European Journal of Cancer, vol.51, issue.13, pp.1742-50, 1990.
DOI : 10.1016/j.ejca.2015.05.015

S. Guntupalli, I. Zighelboim, N. Kizer, Q. Zhang, M. Powell et al., Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer, Gynecologic Oncology, vol.124, issue.1, pp.31-36, 2012.
DOI : 10.1016/j.ygyno.2011.09.017

A. Sadozye, R. Harrand, and N. Reed, Lymphovascular Space Invasion as a Risk Factor in Early Endometrial Cancer, Current Oncology Reports, vol.104, issue.21, pp.24-35, 2016.
DOI : 10.1093/jnci/djs374

P. Jensen, G. Hansen, D. Iachina, M. Mogensen, and O. , Diagnosis, Treatment and Follow-up The nature of early-stage endometrial cancer recurrence-A national cohort study, ESGO-ESTRO Consensus Conference on Endometrial Cancer2?30. 12. Jeppesen MM, pp.51-60, 1990.

W. Böcker, WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics], Verh Dtsch Ges Pathol, vol.86, pp.116-125, 2002.

A. Albertini, M. Devouassoux-shisheboran, C. Genestie, H. Hollema, N. Reesink et al., Pathology of endometrioid carcinoma Bull Cancer (Paris) janv 2012 Lymphvascular space involvement: an independent prognostic factor in endometrial cancer Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival, 7?12. 15. Briët JM, pp.653-661, 2004.

A. Ayhan, C. Taskiran, C. Celik, K. Yuce, and T. Kucukali, The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer, International Journal of Gynecological Cancer, vol.12, issue.5, pp.448-53, 2002.
DOI : 10.1046/j.1525-1438.2002.t01-1-01133.x

. Systematic-pelvic-lymphadenectomy-vs, no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial):1707?16. 19. Naumann RW. The role of lymphadenectomy in endometrial cancer: was the ASTEC trial doomed by design and are we destined to repeat that mistake?, J Natl Cancer Inst. 3 déc Gynecol Oncol. juill, vol.100126, issue.20, 2008.

A. Mariani, S. Dowdy, W. Cliby, B. Gostout, M. Jones et al., Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer, Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging, 2014.

H. Kim, D. Suh, M. Kim, H. Chung, N. Park et al., Systematic Lymphadenectomy for Survival in Patients with Endometrial Cancer: A Meta-analysis, Japanese Journal of Clinical Oncology, vol.42, issue.5, pp.405-417, 2012.
DOI : 10.1093/jjco/hys019

Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda et al., Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis, 1165?72. 24. Nout RA, Smit VTHBM, 2010.
DOI : 10.1016/S0140-6736(09)62002-X

B. Sorbe, G. Horvath, H. Andersson, K. Boman, C. Lundgren et al., External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma, 1281?8. 26. Creutzberg CL, 2012.
DOI : 10.1097/IGC.0b013e3182643ba0

URL : http://pdfs.journals.lww.com/ijgc/2012/09000/External_Pelvic_and_Vaginal_Irradiation_Versus.30.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1506630633476;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdZoMoYvVBJ0aaX3XRlbtjzP4CqAODBo35TZLimx7zg+E=;hash|I8zj/+6qBYcF/GApmiF5Dg==

A. Wong, C. Cheung, L. Fung, T. Lao, B. Mol et al., Development and validation of prediction models for endometrial cancer in postmenopausal bleeding, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.203, pp.220-224, 2016.
DOI : 10.1016/j.ejogrb.2016.05.004

V. Setiawan, H. Yang, M. Pike, S. Mccann, H. Yu et al., Type I and II Endometrial Cancers: Have They Different Risk Factors?, Journal of Clinical Oncology, vol.31, issue.20, pp.2607-2625, 2013.
DOI : 10.1200/JCO.2012.48.2596

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699726/pdf

K. Esposito, P. Chiodini, A. Capuano, G. Bellastella, M. Maiorino et al., Metabolic syndrome and endometrial cancer: a meta-analysis, Endocrine, vol.11, issue.8, pp.28-36, 2014.
DOI : 10.1089/met.2010.0031

N. Jeong, J. Lee, J. Lee, J. Kim, C. Cho et al., Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women, Gynecologic Oncology, vol.118, issue.1, pp.24-32, 2010.
DOI : 10.1016/j.ygyno.2010.03.001

K. Flegal, B. Graubard, D. Williamson, M. Gail, V. Von-gruenigen et al., Cause-specific excess deaths associated with underweight, overweight, and obesity Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study, JAMA Cancer. 15 déc, vol.298107, issue.3412, pp.2786-91, 2006.

L. Lin, L. Hertan, R. Rengan, and B. Teo, Effect of Body Mass Index on Magnitude of Setup Errors in Patients Treated With Adjuvant Radiotherapy for Endometrial Cancer With Daily Image Guidance, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.2, pp.670-675, 2012.
DOI : 10.1016/j.ijrobp.2011.07.026

S. Modesitt, C. Tian, R. Kryscio, J. Thigpen, M. Randall et al., Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: A Gynecologic Oncology Group study, Gynecologic Oncology, vol.105, issue.1, pp.59-65, 2007.
DOI : 10.1016/j.ygyno.2006.10.045

J. Luo, S. Beresford, C. Chen, R. Chlebowski, L. Garcia et al., Association between diabetes, diabetes treatment and risk of developing endometrial cancer, British Journal of Cancer, vol.11, issue.7, pp.1432-1441, 2014.
DOI : 10.1056/NEJM197512042932303

E. Friberg, N. Orsini, C. Mantzoros, and A. Wolk, Diabetes mellitus and risk of endometrial cancer: a meta-analysis, Diabetologia, vol.89, issue.7, pp.1365-74, 2007.
DOI : 10.1016/S0002-9378(94)70401-5

J. Moline, H. Mahdi, Y. B. Biscotti, C. Roma, A. Heald et al., Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center, 121?6. 40. Kumar S, Podratz KC, 2013.
DOI : 10.1016/j.ygyno.2013.04.022

O. Orekoya, M. Samson, T. Trivedi, S. Vyas, and S. Steck, Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer):38?43. 41 The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review, Gynecol Oncol. janv J Gynecol Surg. 1 juin, vol.13232, issue.13, pp.149-57, 2014.

G. Canlorbe, S. Bendifallah, E. Raimond, O. Graesslin, D. Hudry et al., Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study, 2714?21. 43, pp.2035-2076, 1987.
DOI : 10.1016/j.ygyno.2013.12.006

URL : https://hal.archives-ouvertes.fr/hal-01103385

U. Solmaz, E. Mat, M. Dereli, V. Turan, G. Tosun et al., Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.186, 2015.
DOI : 10.1016/j.ejogrb.2015.01.006

N. Colombo, C. Creutzberg, F. Amant, T. Bosse, A. González-martín et al., What is its prognostic significance in the absence of lymph node metastases?, Lymphovascular space invasion in uterine corpus cancer ESMO- ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up, pp.278-82, 2016.

L. Ouldamer, S. Bendifallah, G. Body, C. Touboul, O. Graesslin et al., Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group, Disponible sur, 2016.
DOI : 10.1016/S0140-6736(09)62002-X

URL : https://hal.archives-ouvertes.fr/hal-01417859

S. Jolly, C. Vargas, T. Kumar, S. Weiner, D. Brabbins et al., The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation, Gynecologic Oncology, vol.103, issue.1
DOI : 10.1016/j.ygyno.2006.01.038

H. Hollema, N. Reesink, J. Aalders, M. Mourits, and K. Ten-hoor, Lymphvascular space involvement: an independent prognostic factor in endometrial cancer, 87?93. 49. Briët JM, pp.799-804, 2005.

D. Cohn, N. Horowitz, D. Mutch, S. Kim, T. Manolitsas et al., Should the Presence of Lymphvascular Space Involvement Be Used to Assign Patients to Adjuvant Therapy Following Hysterectomy for Unstaged Endometrial Cancer?, Gynecologic Oncology, vol.87, issue.3, pp.243-249, 2002.
DOI : 10.1006/gyno.2002.6825

A. Gadducci, A. Cavazzana, S. Cosio, C. Di-cristofano, R. Tana et al., Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer

O. Gemer, A. Arie, T. Levy, M. Gdalevich, M. Lorian et al., Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: Results of a multicenter study, European Journal of Surgical Oncology (EJSO), vol.33, issue.5, pp.644-651, 2007.
DOI : 10.1016/j.ejso.2007.01.009

S. Guntupalli, I. Zighelboim, N. Kizer, Q. Zhang, M. Powell et al., Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer, Gynecologic Oncology, vol.124, issue.1, pp.31-36, 2012.
DOI : 10.1016/j.ygyno.2011.09.017

T. Bosse, E. Peters, C. Creutzberg, I. Jürgenliemk-schulz, J. Jobsen et al., Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer ??? A pooled analysis of PORTEC 1 and 2 trials, European Journal of Cancer, vol.51, issue.13, pp.1742-50, 1990.
DOI : 10.1016/j.ejca.2015.05.015

A. , E. Study-group, P. Blake, A. Swart, J. Orton et al., Adjuvant external beam radiotherapy in the treatment of endometrial cancer

N. Johnson, H. Kitchener, and T. Lawrie, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis, Lancet Lond Engl. 22 avr J Natl Cancer Inst, vol.355104, issue.21, pp.1625-1659, 2000.

B. Sorbe, G. Horvath, H. Andersson, K. Boman, C. Lundgren et al., External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma, International Journal of Gynecological Cancer, vol.22, issue.7, pp.1281-1289, 2012.
DOI : 10.1097/IGC.0b013e3182643ba0

B. Sorbe, G. Horvath, H. Andersson, K. Boman, C. Lundgren et al., External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial Carcinoma, ):1281?8. 62. de Boer SM, 2012.
DOI : 10.1097/IGC.0b013e3182643ba0

E. Banasik, Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health- Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial, Int J Radiat Oncol Biol Phys. 15 nov, vol.93, issue.4, pp.797-809, 2015.

H. Karabuga, M. Gultekin, G. Tulunay, K. Yuce, A. Ayhan et al., Assessing the Quality of Life in Patients With Endometrial Cancer Treated With Adjuvant Radiotherapy, International Journal of Gynecological Cancer, vol.25, issue.8, pp.1526-1559, 2015.
DOI : 10.1097/IGC.0000000000000509

M. Becker, T. Malafy, M. Bossart, K. Henne, G. Gitsch et al., Quality of life and sexual functioning in endometrial cancer survivors Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy, ):169?73. 65. Quick AM703?8. 66. Jhingran A, pp.1366-72, 2003.

J. Vargo, H. Kim, C. Houser, H. Berhane, P. Sukumvanich et al., Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification, Radiotherapy and Oncology, vol.113, issue.1, pp.126-157, 2014.
DOI : 10.1016/j.radonc.2014.08.038